Through research in the Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic is leading scientific advances in multiple sclerosis treatment.
It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...
Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...
TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...
The Center for Multiple Sclerosis and Autoimmune Neurology is advancing the use of stem cells in neurological conditions. In stem cell therapy, young cells derived from bone marrow are used to treat ...
Autoimmune encephalitis is a complex category of disease with diverse immunological associations and clinical manifestations. The Center for Multiple Sclerosis and Autoimmune Neurology is recognized ...
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...
Data provided by Mayo Clinic's CT Clinical Innovation Center in an international challenge continue to be used by scientists worldwide and have become a de facto standard set of reference data for use ...
Mayo Clinic cares for nearly 1,100 people with pancreatic cancer each year. In addition, the High-Risk Pancreas Clinic offers people at high risk of developing pancreatic cancer an evaluation and ...
Dr. Erickson's lab creates new informatics tools that can clearly and concisely extract and convey the wealth of information in medical images to improve patient outcomes. In this example, an ...
The Genetics, Epigenetics and Metabolomics Core offers access to the Mayo PKD Clinical Database to study the natural history and genotype-phenotype correlations in autosomal dominant polycystic kidney ...